SpringWorks Therapeutics (NASDAQ:SWTX) Earns “Outperform” Rating from Wedbush
SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report)‘s stock had its “outperform” rating reissued by research analysts at Wedbush in a research report issued on Monday,RTT News reports. They presently have a $77.00 price objective on the stock. Wedbush’s price objective would suggest a potential upside of 39.67% from the company’s current price. Other equities research […]
SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report)‘s stock had its “outperform” rating reissued by research analysts at Wedbush in a research report issued on Monday,RTT News reports. They presently have a $77.00 price objective on the stock. Wedbush’s price objective would suggest a potential upside of 39.67% from the company’s current price. Other equities research […]
